Literature DB >> 22238443

Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa.

Susan E Dorman1, Violet N Chihota, James J Lewis, Minty van der Meulen, Barun Mathema, Natalie Beylis, Katherine L Fielding, Alison D Grant, Gavin J Churchyard.   

Abstract

GenoType MTBDRplus is a molecular assay for detection of Mycobacterium tuberculosis and drug resistance. Assay performance as applied directly to consecutive unselected sputum samples has not been established. The objective of this study was to determine the accuracy of the MTBDRplus test for direct detection of M. tuberculosis (in sputum) and for drug resistance in consecutively submitted sputum samples. In this cross-sectional study in South Africa, one sputum specimen from each person suspected of having pulmonary tuberculosis was tested by smear microscopy, direct MTBDRplus, and Mycobacterial Growth Indicator Tube (MGIT) culture with MGIT drug susceptibility testing. MGIT results were the reference standard. We tested 2,510 sputum samples, and 529 (21.1%) were positive for M. tuberculosis by MGIT. Direct MTBDRplus identified M. tuberculosis in 256 of 529 specimens (sensitivity, 48.4%; 95% confidence interval [CI], 44.1, 52.7). The sensitivity of MTBDRplus for M. tuberculosis detection by sputum smear status was as follows: smear negative, 13.7% (95% CI, 9.8, 18.4); smear scanty, 46.2% (95% CI, 19.2, 74.9); smear 1+, 69.1% (95% CI, 55.2, 80.9); smear 2+, 86.3% (95% CI, 73.7, 94.3); smear 3+, 89.8% (95% CI, 83.7, 94.2). Direct MTBDRplus testing was negative for 1,594/1,612 sputum samples that were culture negative for M. tuberculosis (specificity, 98.9%; 95% CI, 98.2, 99.3). For specimens positive for M. tuberculosis by MTBDRplus, this assay's sensitivity and specificity for rifampin resistance were 85.7% (95% CI, 57.2, 98.2) and 96.6% (95% CI, 93.2, 98.6) and for isoniazid resistance they were 62.1% (95% CI, 42.3, 79.3) and 97.9% (95% CI, 94.8, 99.4). For sputum testing, the sensitivity of MTBDRplus is directly related to the specimen's bacillary burden. Our results support recommendations that the MTBDRplus test not be used for direct testing of smear-negative or paucibacillary sputum samples.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22238443      PMCID: PMC3318561          DOI: 10.1128/JCM.05723-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

Review 1.  Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.

Authors:  S Ramaswamy; J M Musser
Journal:  Tuber Lung Dis       Date:  1998

2.  Comparison of the automated nonradiometric Bactec MGIT 960 system with Löwenstein-Jensen, Coletsos, and Middlebrook 7H11 solid media for recovery of mycobacteria.

Authors:  P Idigoras; X Beristain; A Iturzaeta; D Vicente; E Pérez-Trallero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-05       Impact factor: 3.267

3.  Liquid vs. solid culture for tuberculosis: performance and cost in a resource-constrained setting.

Authors:  V N Chihota; A D Grant; K Fielding; B Ndibongo; A van Zyl; D Muirhead; G J Churchyard
Journal:  Int J Tuberc Lung Dis       Date:  2010-08       Impact factor: 2.373

4.  Performance of the GenoType® MTBDRPlus assay in routine settings: a multicenter study.

Authors:  S Mironova; E Pimkina; I Kontsevaya; V Nikolayevskyy; Y Balabanova; G Skenders; T Kummik; F Drobniewski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-25       Impact factor: 3.267

5.  Application of the Genotype MTBDR assay directly on sputum specimens.

Authors:  D Hillemann; S Rüsch-Gerdes; E Richter
Journal:  Int J Tuberc Lung Dis       Date:  2006-09       Impact factor: 2.373

6.  Comparison of the BACTEC MGIT 960 with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens.

Authors:  H P Chien; M C Yu; M H Wu; T P Lin; K T Luh
Journal:  Int J Tuberc Lung Dis       Date:  2000-09       Impact factor: 2.373

7.  Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus.

Authors:  Elizabeth L Corbett; Gavin J Churchyard; Salome Charalambos; Badara Samb; Vicky Moloi; Tim C Clayton; Alison D Grant; Jill Murray; Richard J Hayes; Kevin M De Cock
Journal:  Clin Infect Dis       Date:  2002-04-05       Impact factor: 9.079

8.  Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa.

Authors:  Alistair D Calver; Alecia A Falmer; Megan Murray; Odelia J Strauss; Elizabeth M Streicher; Madelene Hanekom; Thelma Liversage; Mothusi Masibi; Paul D van Helden; Robin M Warren; Thomas C Victor
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

9.  HIV infection does not affect active case finding of tuberculosis in South African gold miners.

Authors:  James J Lewis; Salome Charalambous; John H Day; Katherine L Fielding; Alison D Grant; Richard J Hayes; Elizabeth L Corbett; Gavin J Churchyard
Journal:  Am J Respir Crit Care Med       Date:  2009-09-10       Impact factor: 21.405

10.  Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults.

Authors:  David W Dowdy; Maria C Lourenço; Solange C Cavalcante; Valeria Saraceni; Bonnie King; Jonathan E Golub; David Bishai; Betina Durovni; Richard E Chaisson; Susan E Dorman
Journal:  PLoS One       Date:  2008-12-29       Impact factor: 3.240

View more
  18 in total

1.  Diagnostic Accuracy and Utility of FluoroType MTBDR, a New Molecular Assay for Multidrug-Resistant Tuberculosis.

Authors:  Margaretha de Vos; Brigitta Derendinger; Tania Dolby; John Simpson; Paul D van Helden; John E Rice; Lawrence J Wangh; Grant Theron; Robin M Warren
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

2.  A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis.

Authors:  M Seifert; K Ajbani; S B Georghiou; D Catanzaro; C Rodrigues; V Crudu; T C Victor; R S Garfein; A Catanzaro; T C Rodwell
Journal:  Int J Tuberc Lung Dis       Date:  2016-05       Impact factor: 2.373

3.  Utility of Targeted, Amplicon-Based Deep Sequencing To Detect Resistance to First-Line Tuberculosis Drugs in Botswana.

Authors:  Nicola M Zetola; Sanghyuk S Shin; Qiao Wang; Chawangwa Modongo; Christopher Allender; David M Engelthaler; Robin M Warren
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

4.  Implementation of genotype MTBDRplus reduces time to multidrug-resistant tuberculosis therapy initiation in South Africa.

Authors:  Karen R Jacobson; Danie Theron; Emily A Kendall; Molly F Franke; Marinus Barnard; Paul D van Helden; Tommie C Victor; Elizabeth M Streicher; Megan B Murray; Robin M Warren
Journal:  Clin Infect Dis       Date:  2012-10-22       Impact factor: 9.079

5.  Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB.

Authors:  Anne F Luetkemeyer; Michelle A Kendall; Xingye Wu; Maria Cristina Lourenço; Ute Jentsch; Susan Swindells; Sarojini S Qasba; Jorge Sanchez; Diane V Havlir; Beatriz Grinsztejn; Ian M Sanne; Cynthia Firnhaber
Journal:  J Clin Microbiol       Date:  2014-01-15       Impact factor: 5.948

6.  Rapid Detection of Rifampicin and Isoniazid Resistant Mycobacterium tuberculosis Using Genotype MTBDRplus Assay in Nepal.

Authors:  Bijay Kumar Sharma; Shiva Bhandari; Bhagwan Maharjan; Bhawana Shrestha; Megha Raj Banjara
Journal:  Int Sch Res Notices       Date:  2014-10-28

7.  "Proof-of-concept" evaluation of an automated sputum smear microscopy system for tuberculosis diagnosis.

Authors:  James J Lewis; Violet N Chihota; Minty van der Meulen; P Bernard Fourie; Katherine L Fielding; Alison D Grant; Susan E Dorman; Gavin J Churchyard
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

8.  Using Xpert MTB/RIF.

Authors:  Mark P Nicol; Andrew Whitelaw; Stevens Wendy
Journal:  Curr Respir Med Rev       Date:  2013-06

9.  Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India.

Authors:  Raj N Yadav; Binit K Singh; Surendra K Sharma; Rohini Sharma; Manish Soneja; Vishnubhatla Sreenivas; Vithal P Myneedu; Mahmud Hanif; Ashok Kumar; Kuldeep S Sachdeva; Chinnambedu N Paramasivan; Balasangameshwra Vollepore; Rahul Thakur; Neeraj Raizada; Suresh K Arora; Sanjeev Sinha
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

10.  GenoType MTBDRplus Assay for Rapid Detection of Multidrug Resistance in Mycobacterium tuberculosis: A Meta-Analysis.

Authors:  Yuanyuan Bai; Yueling Wang; Chunhong Shao; Yingying Hao; Yan Jin
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.